全文获取类型
收费全文 | 49263篇 |
免费 | 4399篇 |
国内免费 | 770篇 |
专业分类
耳鼻咽喉 | 615篇 |
儿科学 | 1237篇 |
妇产科学 | 1372篇 |
基础医学 | 6294篇 |
口腔科学 | 1246篇 |
临床医学 | 5043篇 |
内科学 | 9842篇 |
皮肤病学 | 992篇 |
神经病学 | 3418篇 |
特种医学 | 1554篇 |
外国民族医学 | 3篇 |
外科学 | 6945篇 |
综合类 | 2308篇 |
现状与发展 | 1篇 |
一般理论 | 36篇 |
预防医学 | 2774篇 |
眼科学 | 1933篇 |
药学 | 4037篇 |
5篇 | |
中国医学 | 685篇 |
肿瘤学 | 4092篇 |
出版年
2023年 | 409篇 |
2022年 | 369篇 |
2021年 | 1281篇 |
2020年 | 1031篇 |
2019年 | 1317篇 |
2018年 | 1540篇 |
2017年 | 1229篇 |
2016年 | 1334篇 |
2015年 | 1688篇 |
2014年 | 2190篇 |
2013年 | 2494篇 |
2012年 | 3464篇 |
2011年 | 3599篇 |
2010年 | 2255篇 |
2009年 | 1887篇 |
2008年 | 2784篇 |
2007年 | 2818篇 |
2006年 | 2787篇 |
2005年 | 2636篇 |
2004年 | 2322篇 |
2003年 | 2101篇 |
2002年 | 1896篇 |
2001年 | 1390篇 |
2000年 | 1298篇 |
1999年 | 1095篇 |
1998年 | 449篇 |
1997年 | 361篇 |
1996年 | 316篇 |
1995年 | 274篇 |
1994年 | 275篇 |
1993年 | 273篇 |
1992年 | 558篇 |
1991年 | 552篇 |
1990年 | 520篇 |
1989年 | 479篇 |
1988年 | 408篇 |
1987年 | 417篇 |
1986年 | 359篇 |
1985年 | 300篇 |
1984年 | 231篇 |
1983年 | 166篇 |
1982年 | 105篇 |
1981年 | 100篇 |
1980年 | 106篇 |
1979年 | 158篇 |
1978年 | 98篇 |
1977年 | 87篇 |
1976年 | 82篇 |
1975年 | 84篇 |
1974年 | 74篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
感染性疾病对老年人危害严重,接种疫苗是预防感染的有效手段。但我国常见感染性疾病疫苗的整体接种率偏低,基层医务人员及居民对疫苗接种的认知存在不足。《社区老年人常见感染性疾病疫苗应用专家共识》针对流感疫苗、肺炎球菌疫苗和带状疱疹疫苗3种常见疫苗的接种给予了详细的指导,旨在提高基层医务人员对老年人群疫苗接种的重视程度,加强其对公众的疫苗接种宣传教育,医防协同,共同助力提高老年人群健康水平。 相似文献
4.
5.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
6.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
7.
8.
Chi Yuen Cheung Mei Lan Pong Suk Fun Au Yeung Wai Leung Chak 《Transplantation proceedings》2021,53(4):1143-1145
IntroductionThe coronavirus disease 2019 (COVID-19) pandemic was expected to have a negative impact on organ donation. With the differences in health care systems and lockdown policies in various regions, the pandemic's effect on organ donation and transplant service may vary. Most of the deceased donor organ referrals in our hospital came from non–intensive care units (ICUs). The objective of this study is to report our experience and quantify the effects of the COVID-19 pandemic on deceased donor organ donation in our center.MethodsThis was a retrospective observational study comparing the deceased donor organ donation activity during the period January 23 to November 30, 2020 with the same period in 2018 in Queen Elizabeth Hospital, Hong Kong.ResultsThere was a 26.9% reduction in deceased donor organ donor referral in 2020 compared with 2018. No significant difference in the proportion of referrals from ICU or non-ICU areas between the 2 time periods was observed. The brain death confirmation rate was significantly higher in 2020 (40.8% vs 20.2%, P = .003). Nine patients had family consent for organ donation in 2020 (vs 7 patients in the same period in 2018). There were no significant differences in consent rate and number of recovered organs between the 2 periods.ConclusionsWith effective measures to limit the spread of COVID-19 in a community, it is possible to support the needs of both patients with COVID-19 and deceased donor organ donation services. 相似文献
9.
10.
Matrine,oxymatrine, and compound Kushen injection from the roots of Sophora flavescens: an overview of their anticancer activities 下载免费PDF全文
In the present review, we updated current information on the chemistry, contents, and anticancer properties of matrine (MT), oxymatrine (OMT), and compound Kushen injection (CKI). The anticancer properties were focused on lung, breast, and liver cancer cells because they are most susceptible. Sources of information were from Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, Directory of Open Access Journals (DOAJ), and China National Knowledge Infrastructure (CNKI). Reference was also made on botanical websites, such as Flora of China and World Flora Online. MT and OMT are dominant quinolizidine alkaloids from the roots of Sophora flavescens (Kushen) of the family Fabaceae. Against lung, breast, and liver cancer cells, MT and OMT inhibit cell proliferation; induce cell cycle arrest, apoptosis, and autophagy; restrict angiogenesis; and inhibit cell metastasis, invasion, and migration. The processes involve various molecular targets and signaling pathways. CKI is a traditional Chinese medicine (TCM) composed of root extracts of S. flavescens and Smilax glabra (Baituling) of the family Smilacaceae. With MT and OMT as major components, CKI has been approved for the treatment of cancer in China more than 20 years ago. In recent years, systematic reviews and meta-analysis have been undertaken to evaluate the anticancer effects of CKI. When CKI is used alone and in combination with chemotherapy of western medicine, there is much to be learned concerning their interactions besides their individual and integrated efficacy. Some perspectives of MT, OMT, and CKI are discussed, and their suggestions for future research are provided. 相似文献